ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD

Background & Aims: Identifying fibrosis in non-alcoholic fatty liver disease (NAFLD) is essential to predict liver-related outcomes and guide treatment decisions. A protein-based signature of fibrosis could serve as a valuable, non-invasive diagnostic tool. This study sought to identify circulat...

Full description

Bibliographic Details
Main Authors: Corey, K.E (Author), Finkel, N. (Author), Gee, D.W (Author), Gerszten, R.E (Author), Gustafson, J.L (Author), Hutter, M.M (Author), Jacob, J. (Author), Jennings, L.L (Author), Lai, M. (Author), Loureiro, J. (Author), Masia, R. (Author), Meireles, O.R (Author), Ngo, D. (Author), Osganian, S.A (Author), Pitts, R. (Author), Richards, S.M (Author), Ukomadu, C. (Author), Wang, T.J (Author), Witkowski, E.R (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2022
Subjects:
Online Access:View Fulltext in Publisher